This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1968 Feb;15(1):43-55.

doi: 10.1016/s0031-3955(16)32087-9.

The tetracyclines

PMID: 4866906
DOI: 10.1016/s0031-3955(16)32087-9

Review

The tetracyclines

C M Kunin. Pediatr Clin North Am. 1968 Feb.

. 1968 Feb;15(1):43-55.

doi: 10.1016/s0031-3955(16)32087-9.

Author

PMID: 4866906
DOI: 10.1016/s0031-3955(16)32087-9

No abstract available

PubMed Disclaimer

Similar articles

The biochemistry and the physiology of the tetracyclines: with special reference to mineralized tissues.
Ibsen KH, Urist MR. Ibsen KH, et al. Clin Orthop Relat Res. 1964 Jan-Feb;32:143-69. Clin Orthop Relat Res. 1964. PMID: 4873463 Review. No abstract available.
Correlation of in vitro resistance of Staphylococcus aureus to tetracycline, doxycycline, and minocycline with in vivo use.
Lewis SA, Altemeier WA. Lewis SA, et al. Chemotherapy. 1976;22(5):319-23. doi: 10.1159/000221939. Chemotherapy. 1976. PMID: 947710
Antibacterial and inducer activities for tetracycline resistance by its derivates and analogues.
Inoue M, Kazawa T, Mitsuhashi S. Inoue M, et al. Microbiol Immunol. 1977;21(2):59-67. doi: 10.1111/j.1348-0421.1977.tb02808.x. Microbiol Immunol. 1977. PMID: 870795
Letter: Activity of minocycline against Bacteroids fragilis.
Leigh DA, Simmons K. Leigh DA, et al. Lancet. 1975 Jan 4;1(7897):51. doi: 10.1016/s0140-6736(75)92424-1. Lancet. 1975. PMID: 46948 No abstract available.
[20 years of tetracycline chemiotherapy. II. Pharmacology. Therapeutic use].
Periti P, Perretti F. Periti P, et al. Clin Ter. 1968 Mar 31;44(6):523-64. Clin Ter. 1968. PMID: 4899458 Review. Italian. No abstract available.

See all similar articles

Cited by

Amikacin sulfate levels in human serum and bile.
Bermúdez RH, Lugo A, Ramírez-Ronda CH, Amadeo JA, Morales J. Bermúdez RH, et al. Antimicrob Agents Chemother. 1981 Feb;19(2):352-4. doi: 10.1128/AAC.19.2.352. Antimicrob Agents Chemother. 1981. PMID: 7347566 Free PMC article.
Bone Targeting Nanoparticles for the Treatment of Osteoporosis.
Wen C, Xu X, Zhang Y, Xia J, Liang Y, Xu L. Wen C, et al. Int J Nanomedicine. 2024 Feb 12;19:1363-1383. doi: 10.2147/IJN.S444347. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38371454 Free PMC article. Review.
Integrating osteoimmunology and nanoparticle-based drug delivery systems for enhanced fracture healing.
Xiao B, Adjei-Sowah E, Benoit DSW. Xiao B, et al. Nanomedicine. 2024 Feb;56:102727. doi: 10.1016/j.nano.2023.102727. Epub 2023 Dec 8. Nanomedicine. 2024. PMID: 38056586 Free PMC article. Review.
7-Chlorolincomycin therapy of pulmonary infections due to Myoplasma pneumoniae.
Axelrod J, Meyers BR, Hirschman SZ. Axelrod J, et al. Antimicrob Agents Chemother. 1972 Dec;2(6):499-501. doi: 10.1128/AAC.2.6.499. Antimicrob Agents Chemother. 1972. PMID: 4596744 Free PMC article. Clinical Trial.
Bone-Targeted Nanoparticle Drug Delivery System: An Emerging Strategy for Bone-Related Disease.
Chen Y, Wu X, Li J, Jiang Y, Xu K, Su J. Chen Y, et al. Front Pharmacol. 2022 May 31;13:909408. doi: 10.3389/fphar.2022.909408. eCollection 2022. Front Pharmacol. 2022. PMID: 35712701 Free PMC article. Review.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science